Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

7.7%

2 terminated out of 26 trials

Success Rate

88.2%

+1.7% vs benchmark

Late-Stage Pipeline

27%

7 trials in Phase 3/4

Results Transparency

40%

6 of 15 completed with results

Key Signals

6 with results88% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (2)
P 1 (3)
P 2 (3)
P 3 (2)
P 4 (5)

Trial Status

Completed15
Unknown5
Terminated2
Suspended1
Withdrawn1
Active Not Recruiting1

Trial Success Rate

88.2%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (26)

Showing 20 of 20 trials
NCT05033119CompletedPrimary

PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics

NCT04746313Completed

Prevalence of Hyperprolactinemia in Systemic Scleroderma

NCT07008417Phase 1Active Not RecruitingPrimary

A Study on Bioequivalence of Cabergoline Tablets in Human Body

NCT07124221Phase 3RecruitingPrimary

A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate Tablets

NCT02956447Phase 2CompletedPrimary

Administration of Kisspeptin in Patients With Hyperprolactinemia

NCT00914823Phase 1Completed

Kisspeptin Administration in the Adult

NCT03038308Phase 1CompletedPrimary

Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole

NCT06326840Not ApplicableCompleted

Clinical Efficacy and Adverse Reactions of Antipsychotic Treatment

NCT04146389TerminatedPrimary

Hyperprolactinemia and Adrenal Steroidogenesis

NCT04439747UnknownPrimary

Develop and Implement Methods for Diagnostic and Treatment of Hormonal Disorders in Patients With Chronic Kidney Disease

NCT01338298Not ApplicableCompletedPrimary

Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With Schizophrenia

NCT02603549SuspendedPrimary

Pituitary Function and Spontaneous Intracranial Hypotension

NCT03709849Phase 2Unknown

Effectiveness and Safety of Bushen Culuan Decoction for Anovulatory Infertility

NCT00889512Phase 4Terminated

The Luveris In Vitro Fertilization Trial

NCT03569787CompletedPrimary

Hyperprolactinaemia Management in Reproductive Services at University Hospital of Coventry and Warwickshire

NCT00699530WithdrawnPrimary

Substrate Metabolism and Insulin Sensitivity in Patients With Hyperprolactinemia Before and After Treatment

NCT02098668Completed

Mathematical Model for the Human Menstrual Cycle, Endocrinological Diseases and Fertility Treatment-PAEON

NCT01085383Phase 4CompletedPrimary

Aripiprazole and Prolactin Study

NCT01852331Phase 2Completed

Peony-Glycyrrhiza Decoction (PGD) for Antipsychotic-induced Hyperprolactinemia in Patients With Schizophrenia

NCT01270711Completed

Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)

Scroll to load more

Research Network

Activity Timeline